California Public Employees Retirement System Rapt Therapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$17.99 - $40.02 $402,975 - $896,448
-22,400 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$16.0 - $24.46 $33,232 - $50,803
-2,077 Reduced 8.49%
22,400 $497,000
Q4 2020

Feb 02, 2021
SELL
$15.89 - $40.87 $7,945 - $20,435
-500 Reduced 2.0%
24,477 $483,000
Q3 2020

Nov 05, 2020
BUY
$21.6 - $37.5 $15,120 - $26,250
700 Added 2.88%
24,977 $804,000
Q2 2020

Aug 12, 2020
BUY
$14.16 - $32.85 $343,762 - $797,499
24,277 New
24,277 $705,000

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $26.1M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email